Login to Apply

A pharmaceutical company is looking for a driven and curious Senior Scientist with strong experience in CAR T cell design, synthesis and in-vitro functional testing. This role sits at the heart of an exciting research programme applying CAR T technology to targeted cell depletion, with longer-term potential across drug discovery, immune reset and tissue regeneration.

You’ll play a hands-on role in shaping and advancing a growing platform at the intersection of cellular immunotherapy and regenerative medicine, working alongside highly collaborative, cross-functional teams.

What you’ll be doing

* Designing and constructing CAR T cell vectors targeting selected antigens

* Developing and optimising CAR T cell synthesis, transduction and expansion protocols

* Running in-vitro functional assays, including cytotoxicity, cytokine release and persistence studies

* Supporting drug discovery programmes focused on immune modulation and tissue repair

* Analysing data, preparing technical reports and presenting findings internally

* Keeping up to date with emerging CAR T technologies and feeding ideas into platform strategy

What we’re looking for

* MSc or PhD in Immunology, Cell Biology, Molecular Biology or a related field

* Hands-on experience with CAR T cell design and functional testing

* Strong background in vector construction, T cell engineering and in-vitro assays

* Solid understanding of immune cell biology and targeted cell depletion

* Comfortable working independently while thriving in a collaborative, fast-moving environment

* Clear communicator with strong problem-solving skills and great attention to detail

This is a genuine opportunity to work on forward-thinking science with real long-term impact, in an environment that values ideas, ownership and collaboration.

This role is offered on an initial 12 month contract with potential for extension

Keywords: CAR T Cell, Chimeric Antigen Receptor T-cell, research, development, pharmaceutical, biotechnology, in vitro assay, flow cytometry, ELISA, cell biology, immunology, London, Slough, Reading, Oxford, VRS9341SE